Catalyst Wire Dossier Catalyst Wire Dossier

Neu-P11

· Neurim Pharmaceuticals Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Neu-P11, covering 2011-04-07 to 2018-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Sleep Laboratory Study to Investigate the Safety and Efficacy of Neu-P11 in Primary Insomnia Patients [Phase 2]

See pricing